Beta
Back to CVS.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
cash-and-debt-chart

CVS Cash & Debt

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

As of Q4'25, CVS's cash and short-term investments stood at $10.66B USD, reflecting a modest decline of approximately 5.5% from the $11.29B USD reported in Q3'25. Meanwhile, total debt was $79.95B USD, down slightly by about 2.2% from the previous quarter's $81.75B USD, resulting in a net debt position of around $69.29B USD. Over the period from Q1'23 to Q4'25, cash and short-term investments exhibited volatility, starting at a high of $17.72B USD in Q1'23 before dropping sharply to $9.68B USD in Q3'24, then recovering to $14.22B USD in Q2'25, and ultimately trending downward to $10.66B USD amid inconsistent quarterly fluctuations. In contrast, debt levels remained relatively stable, fluctuating between $76.48B USD and $83.82B USD, with a gradual moderation to $79.95B USD by Q4'25, indicating sustained leverage without significant expansion or reduction. This dynamic suggests CVS maintained liquidity buffers against a backdrop of steady indebtedness, though the narrowing cash position in recent quarters may warrant monitoring for potential liquidity pressures.